The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
|
journal
|
June 1998 |
Structure and function in rhodopsin: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line
|
journal
|
October 2002 |
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
|
journal
|
August 2013 |
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
|
journal
|
September 2012 |
Recent progress in broadly neutralizing antibodies to HIV
|
journal
|
October 2018 |
Broad neutralization coverage of HIV by multiple highly potent antibodies
|
journal
|
September 2011 |
HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
|
journal
|
November 2018 |
Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies
|
journal
|
May 2013 |
Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers
|
journal
|
May 2014 |
Neutralization tiers of HIV-1
|
journal
|
January 2018 |
Potent and broad HIV-neutralizing antibodies in memory B cells and plasma
|
journal
|
January 2017 |
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
|
journal
|
July 2011 |
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
|
journal
|
February 2016 |
Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
|
journal
|
May 2014 |
The quest for an antibody-based HIV vaccine
|
journal
|
January 2017 |
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
|
journal
|
June 2018 |
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
|
journal
|
September 2013 |
Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer
|
journal
|
February 2017 |
Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
|
journal
|
November 1994 |
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
|
journal
|
March 2013 |
Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex
|
journal
|
November 2014 |
New tools for automated high-resolution cryo-EM structure determination in RELION-3
|
journal
|
November 2018 |
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
|
journal
|
December 2015 |
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|
journal
|
July 2010 |
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates
|
journal
|
February 2017 |
Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation
|
journal
|
May 2018 |
HIV-1 Fitness Cost Associated with Escape from the VRC01 Class of CD4 Binding Site Neutralizing Antibodies
|
journal
|
January 2015 |
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
|
journal
|
April 2013 |
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo
|
journal
|
August 2017 |
UCSF Chimera?A visualization system for exploratory research and analysis
|
journal
|
January 2004 |
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
|
journal
|
April 2016 |
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models
|
journal
|
December 2017 |
HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies
|
journal
|
March 2016 |
Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies
|
journal
|
May 2018 |
Host controls of HIV broadly neutralizing antibody development
|
journal
|
January 2017 |
Gctf: Real-time CTF determination and correction
|
journal
|
January 2016 |
Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1IIIB gp120
|
journal
|
December 2001 |
Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta
|
journal
|
September 2016 |
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
|
journal
|
July 2010 |
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
|
journal
|
August 2017 |
Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains
|
journal
|
December 2017 |
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
|
journal
|
October 2012 |
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
|
journal
|
November 2016 |
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions
|
journal
|
October 2014 |
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
|
journal
|
July 2014 |
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein
|
journal
|
March 2016 |
Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades
|
journal
|
September 2002 |
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function
|
journal
|
June 2010 |
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
|
journal
|
December 2015 |
MolProbity : all-atom structure validation for macromolecular crystallography
|
journal
|
December 2009 |
Host Controls of HIV Neutralizing Antibodies
|
journal
|
May 2014 |
Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers
|
journal
|
December 2015 |
Global site-specific N-glycosylation analysis of HIV envelope glycoprotein
|
journal
|
March 2017 |
Features and development of Coot
|
journal
|
March 2010 |
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
|
journal
|
January 2010 |
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
|
journal
|
March 2013 |
EMRinger: side chain–directed model and map validation for 3D cryo-electron microscopy
|
journal
|
August 2015 |
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
|
journal
|
May 2018 |
Cross-Clade Neutralizing Activity of Human Anti-V3 Monoclonal Antibodies Derived from the Cells of Individuals Infected with Non-B Clades of Human Immunodeficiency Virus Type 1
|
journal
|
June 2006 |
Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
|
journal
|
June 2011 |
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
|
journal
|
June 2005 |
Antibodies in HIV-1 Vaccine Development and Therapy
|
journal
|
September 2013 |
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
|
journal
|
June 2017 |
Antibody neutralization and escape by HIV-1
|
journal
|
March 2003 |
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
|
journal
|
May 2016 |
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
|
journal
|
October 2012 |
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
|
journal
|
April 2017 |
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
|
journal
|
June 2015 |
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
|
journal
|
September 2012 |
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
|
journal
|
August 2011 |
Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies
|
journal
|
August 2013 |
The V3 Loop Is Accessible on the Surface of Most Human Immunodeficiency Virus Type 1 Primary Isolates and Serves as a Neutralization Epitope
|
journal
|
March 2004 |
Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1
|
journal
|
February 2009 |
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
|
journal
|
February 2017 |
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
|
journal
|
June 2015 |
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
|
journal
|
December 2002 |
Exploring the gas access routes in a [NiFeSe] hydrogenase using crystals pressurized with krypton and oxygen
|
journal
|
August 2020 |
PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome
|
journal
|
December 2019 |
Insights on autophagosome–lysosome tethering from structural and biochemical characterization of human autophagy factor EPG5
|
journal
|
March 2021 |
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
|
text
|
January 2013 |
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
|
text
|
January 2015 |
Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
|
text
|
January 2014 |
Functional consequences of allotypic polymorphisms in human immunoglobulin G subclasses
|
journal
|
July 2022 |
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
|
journal
|
August 2019 |
HIV Broadly Neutralizing Antibodies: Taking Good Care Of The 98%
|
journal
|
November 2016 |
Mechanism of AAA+ ATPase-mediated RuvAB–Holliday junction branch migration
|
journal
|
August 2022 |
Utilizing gnotobiotic models to inform the role of the microbiome in vaccine response heterogeneity
|
journal
|
January 2018 |
Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion
|
journal
|
November 2012 |
Epitopes Immediately below the Base of the V3 Loop of gp120 as Targets for the Initial Autologous Neutralizing Antibody Response in Two HIV-1 Subtype B-Infected Individuals
|
journal
|
July 2011 |
Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design
|
journal
|
February 2012 |
Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry.
|
journal
|
January 1995 |
Mapping of Epitopes Exposed on Intact Human Immunodeficiency Virus Type 1 (HIV-1) Virions: a New Strategy for Studying the Immunologic Relatedness of HIV-1
|
journal
|
November 1998 |